Remove Diabetes Remove Heart attacks Remove Obesity
article thumbnail

Heart Disease and Stroke Could Affect at Least 60% of Adults in U.S. by 2050, According to American Heart Association Advisories

DAIC

A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 trillion by 2050, according to two American Heart Association ( AHA ) presidential advisories published June 4 in the AHA journal Circulation. "The

article thumbnail

How Apob & Visceral Fat Increase Your Risk Of Heart Disease.

Dr. Paddy Barrett

The greater the number of particles the artery wall is exposed to over time, the higher the risk of atherosclerosis and a heart attack 2. Visceral Fat & Insulin Resistance While rates of smoking have decreased significantly in recent decades, the rates of obesity and excess visceral fat have increased dramatically 3.

article thumbnail

Five Things Every Middle Aged Adult Should Know About Sleep & Heart Disease.

Dr. Paddy Barrett

Insulin resistance is a precursor condition to metabolic syndrome and type 2 diabetes, both major drivers of heart disease. Obesity is one of the biggest global health concerns we face today. Obesity is also a key driver of risk for cardiovascular disease. Poor Sleep Increases The Rate Of Heart Attacks & Stroke.

article thumbnail

Wegovy Gains Expanded Approval for CVD Risk Reduction

CardiacWire

Wegovy’s expanded FDA approval now supports its use for the reduction of major adverse cardiovascular events in obese or overweight adults with established CVD. Semeglutide was already approved for diabetes (via Ozempic) and weight loss (via Wegovy), although payors have largely resisted covering non-diabetic patients.

Obesity 64
article thumbnail

Weight Loss Drugs Land Medicare Coverage for Cardiovascular Events

CardiacWire

Less than two weeks after Novo Nordisk’s weight-loss drug Wegovy gained expanded FDA approval for cardiovascular event risk reduction, CMS issued a new Medicare Part D guidance that allows coverage of obesity drugs for senior patients with “an additional medically accepted indication”… like cardiovascular disease.

article thumbnail

Abstract TP268: Xylitol, Xylose, and MicroRNAs Associated with Thrombosis and the Clotting Cascade in a Multi-Omics Cross-Sectional Study of Adults at Risk for Type 2 Diabetes and Stroke

Stroke Journal

Introduction:Xylitol, a sugar alcohol with a global market estimated at 161,500 metric tons, has been linked to increased thrombosis and risk of stroke and heart attack. However, multiomics studies of both xylitol metabolites and these miRs in humans have not been done.

article thumbnail

Abstract 4140513: Temporal Trends in Cardiovascular Risk Factors and Cardiovascular Disease Among Subgroups of Asian Americans in the United States

Circulation

Age-standardized prevalence rates were calculated for eight conditions, including hypertension, type 2 diabetes, alcohol use, smoking, physical inactivity, overweight/obesity, short sleep (< 7 hours), and CVD (defined as having coronary heart disease, heart attack, or stroke). p< 0.001).